Goldman Sachs: Fed has good reason to cut rates in July
On July 15, Goldman Sachs chief economist Jan Hatzius said they believe the Fed has "good reason" to cut interest rates at its July meeting, but did not change their prediction that the Fed will start cutting rates in September. According to the latest unemployment and inflation data, a federal funds rate of 4% is appropriate, compared to the current 5.25%-5.5%. As a result, rate cuts are expected to begin soon.
Reasons for acting in July include the volatility of monthly inflation, which could make a September rate cut difficult to explain if there is a temporary re-acceleration, and the undeniable motivation of the Fed in 'avoiding the start of rate cuts in the last two months of the presidential campaign'. While this does not mean that the Fed cannot start cutting rates in September, it is true that July would be more appropriate.
Translated with DeepL.com (free version)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
